1Life Healthcare
ONEM
ONEM was delisted on the 21st of February, 2023.
90 hedge funds and large institutions have $1.26B invested in 1Life Healthcare in 2020 Q1 according to their latest regulatory filings, with 90 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
23% less call options, than puts
Call options by funds: $301K | Put options by funds: $392K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carlyle Group
Washington,
District of Columbia
|
+$617M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$209M |
| 3 |
AI
Alphabet Inc
Mountain View,
California
|
+$136M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$131M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$68.5M |
Top Sellers
ONEM Hedge Fund Activity: Q1 2020 in Review
90 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in 1Life Healthcare (ONEM) for Q1 2020, worth a combined $1.26B.
Buyers outnumbered sellers: 90 funds opened new ONEM positions and 0 closed out — a net gain of 90 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Carlyle Group, opening a new position worth an estimated $617M.
- 90 institutional investors held 1Life Healthcare (ONEM) as of Q1 2020, up from 0 in Q4 2019.
- Funds reported $1.26B of 1Life Healthcare stock for Q1 2020.
- 90 funds opened new 1Life Healthcare positions in Q1 2020 and 0 closed out, a net change of +90 holders.
- The largest 1Life Healthcare buyer in Q1 2020 was Carlyle Group, an estimated $617M added.
Based on aggregated 13F filings for Q1 2020.